Skip to main content
CCLD logo

CCLD · CareCloud, Inc.

Track CCLD — free
$2.31 -0.11 (-4.55%)
Market Cap
$102.97M
Shares
42.55M
Volume · Nov 16 270.13K Avg daily vol (3M) 373.17K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.42 Open$2.59 Day$2.28–2.60 52W close$1.71–3.81 Avg vol 30d458K Short int680K · 1.6% of shares · 3.6d Short vol49% Last earningsNov 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

Mar 11, 2027 Est · unconfirmed · in 16 wks

Latest documents

2026
Nov 5
Earnings call
Record profitability drives stronger shareholder earnings

CareCloud reported its most profitable third quarter, with revenue of $33.7 million, net income of $4.7 million and record adjusted EBITDA of $9.9 million, and reaffirmed full-year 2026 guidance.

5 source passages
the third quarter was the most profitable quarter in CareCloud's history. Third quarter revenue was $33.7 million, up 9% from a year ago. Gap net income was a record $4.7 million, up 54% year over year. adjusted EBITDA was a record $9.9 million, up 28% year-over-year. We are reaffirming our full-year 2026 guidance. Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 13% as operating margins improve

CareCloud's nine-month net revenue rose $10.8 million, or 13%, to $96.9 million from $86.1 million. GAAP operating margin improved to 9.7% from 9.6%, while adjusted operating margin increased to 13.2% from 11.8%.

Revenue $33.73M ▲ 8.6% Net income $4.73M ▲ 54.5% Diluted EPS $0.10 ▲ 150.0%
Read from the MD&A section
4 source passages
CareCloud cirrusAI integrates with CareCloud’s EHR solutions, talkEHR and CareCloud Charts, making it easily accessible to providers of all sizes. Net revenue of $33.7 million and $96.9 million for the three and nine months ended September 30, 2026, increased by $2.7 million or 9% and $10.8 million or 13% from net revenue of $31.1 million and $86.1 million for the three and nine months ended September 30, 2025, respectively. GAAP operating margin | 19.5% | 10.3% | 9.7% | 9.6% Non-GAAP adjusted operating margin | 22.6% | 14.5% | 13.2% | 11.8% Open the document at this passage
Nov 5
Current report 8-K
Record Q3 Profitability as 2026 Guidance Is Reaffirmed

CareCloud reported its most profitable quarter ever for the quarter ended September 30, 2026, with GAAP net income of $4.7 million, GAAP EPS of $0.10, and adjusted EBITDA of $9.9 million. Management reaffirmed guidance for calendar year 2026.

Financial results, Regulation FD disclosure
3 source passages
CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced record financial results for the quarter ended September 30, 2026. CareCloud delivered the highest quarterly profitability in its history: record GAAP net income of $4.7 million, up 54% year over year from $3.1 million; record GAAP EPS of $0.10, up 150% from $0.04; and record adjusted EBITDA of $9.9 million, up 28% from $7.7 million in the third quarter of 2025. The Company is reaffirming its guidance for calendar year 2026. Open the document at this passage
Sep 29
Current report 8-K Events of Sep 28
Director or officer change, or executive pay

CareCloud appointed Bonnie Boyer Chief Financial Officer effective October 1, 2026, succeeding Norman Roth, who will become Advisor to the Chief Executive Officer. Boyer’s annual base salary is $300,000 with a 30% target bonus.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$131.30M
Trailing 12 months
Net income (TTM)
$9.66M
Trailing 12 months
Revenue growth YoY
+8.6%
Year over year
Operating margin
9.6%
Trailing 12 months
P / E (TTM)
16.1
Trailing earnings · reciprocal yield 6.2%
FCF yield
21.0%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.4%
Year over year · more shares
Price change (1Y)
-23.9%
Trailing year
Short interest
1.6%
Latest settlement · 3.6 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 5, 2026
Q3 FY26

TL;DR. CareCloud delivered record Q3 profitability as revenue grew 9%, margins expanded, AI and automation lowered claim touches, debt declined, and nearly 90% of net income reached common shareholders. Risks include lower nine-month GAAP net income, higher interest expense, lower free cash flow, weaker project-services revenue, remaining Series A preferred stock under evaluation, and customer-dependent guidance.

Bullish
  • + Q3 was CareCloud's most profitable quarter in company history, with record GAAP net income, GAAP EPS, and adjusted EBITDA.
  • + Q3 revenue increased 9% year over year to $33.7 million.
  • + Revenue less direct operating costs improved to 50.5% from 47.8% as revenue grew approximately 9% while direct operating costs increased only 3%.
  • + AI and automation cut manual claim touches by approximately 44% over three months, allowing more volume without additional headcount.
  • + Nearly 90% of Q3 net income accrued to common shareholders, compared with about half a year earlier.
  • + CareCloud repaid its $9 million revolver draw and reduced the term loan to $34.2 million, lowering the debt taken on for the preferred-stock redemption by approximately $7.4 million.
Bearish
  • − Nine-month GAAP net income declined to $6.8 million from $7.9 million in the prior-year period.
  • − Q3 interest expense increased to $1,801 thousand from $147 thousand a year earlier.
  • − Q3 free cash flow declined to $3,789 thousand from $5,668 thousand in the prior-year quarter.
  • − Lower project-based professional services revenue partially offset Q3 growth.
  • − Full-year guidance depends on customer performance, and an impairment in a customer relationship could materially adversely affect results.
  • − Nine-month free cash flow declined to $11,916 thousand from $14,726 thousand in the prior-year period.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −1%
below
Price vs 50-day avg +19%
above
RSI (14) 63
neutral
MACD trend Positive
52-week position 34%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +31%
trailing
6-month return +10%
trailing
YTD return −17%
this year
Relative strength +9%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
50 of 66 funds reported for Sep 30 · net +77.9K sh shares · +6 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.60% of shares out · ▲ +4.0% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
66 holders — mid 3-yr range
Squeeze score 66
elevated · 0–100
Fundamentals
Excellent
Revenue growth +9%
Y/Y
EPS growth +136%
Y/Y
Free cash flow $23.8M
Quant / Vol
risk profile
Very High
Volatility 65%
annualized · 1-yr
Max drawdown −55%
past year
ATR 7.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 7
Latest guidance · from the 8-K filed Nov 5, 2026
Revenue · For the Fiscal Year Ending December 31, 2026 Maintained $128M – $132M
Aug 6, 2026 $128M – $132M changed to Nov 5, 2026 $128M – $132M
prior FY $120.5M midpoint +7.9% Y/Y
Adjusted EBITDA · For the Fiscal Year Ending December 31, 2026 Maintained $29M – $31M
Aug 6, 2026 $29M – $31M changed to Nov 5, 2026 $29M – $31M
GAAP Net Income Per Share (EPS) · For the Fiscal Year Ending December 31, 2026 Maintained $0.20 – $0.23
Aug 6, 2026 $0.20 – $0.23 changed to Nov 5, 2026 $0.20 – $0.23
prior FY $0.10 midpoint +115.0% Y/Y
Guided vs delivered · last 7 settled
Revenue full year 2025
guided $117M – $119M
$120.5M Beat +2.1%
GAAP EPS full year 2025
guided $0.10 – $0.13
$0.10 In line
Revenue fiscal year ending December 31, 2024
guided $118M – $120M
$110.84M Miss −6.9%
Revenue For the Fiscal Year Ending December 31, 2023
guided $120M – $122M
$117.06M Miss −3.3%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−1% Neutral
Price vs 50-day avg
+19% Bullish
RSI (14)
63 Neutral
MACD trend
Positive Bullish
52-week position
34% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
50 of 66 funds reported for Sep 30 · net +77.9K sh shares · +6 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.60% of shares out · ▲ +4.0% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
66 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2 Now $2 · 34% Range high $4
vs 200-day avg -1% vs 50-day avg +19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $11.3M Six Months Ended June 30, 2026 —
Free cash flow non-GAAP $8.13M Six Months Ended June 30, 2026 —
Non-GAAP adjusted earnings per share non-GAAP $0.11 Six Months Ended June 30, 2026 —
Non-GAAP adjusted net income non-GAAP $4.53M Six Months Ended June 30, 2026 —
Non-GAAP adjusted operating income non-GAAP $5.21M Six Months Ended June 30, 2026 —
Non-GAAP adjusted operating margin non-GAAP 8.3% Six Months Ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CCLD
CareCloud, Inc.
this stock
$102.97M -17.1% +8.7% — 1.6%
VEEV
Veeva Systems Inc
$48.82B +35.1% +28.1% 49.4 2.4%
PMDIY
Pro Medicus Ltd.
$14.81B -14.6% — — 0.0%
BTSG
BrightSpring Health Services, Inc.
$14.17B +90.1% +28.2% 38.7 5.8%
TEM
Tempus AI, Inc.
$13.06B +21.3% +83.4% — 13.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
69
% held
22.7%
Reported
50 of 66
Top holder
VANGUARD CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
39
View
Short & Settlement
Short Interest Rising
Shares short
680.0K
Days to cover
3.6d
Change
+25.8K sh
View
Short Volume
Short vol %
49%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
749
Value
$1.5K
As of
Oct 6, 2026
View
Off-Exchange
Off-exchange %
55.0%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Kevin Hern
Amount
$1.0K–$15.0K
Traded
Dec 8, 2023
View
Financials
Financials
Revenue (FY)
$120.5M
Net income (FY)
$10.8M
EPS diluted
$0.10
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 5, 2026
This year
20

CareCloud reported its most profitable quarter ever for the quarter ended September 30, 2026, with GAAP net income of $4.7 million, GAAP EPS of $0.10, and adjusted EBITDA of $9.9 million. Management reaffirmed guidance for calendar year 2026.

View
Proposed Sales
Value
$51.1K
Shares
15.0K
Filed
Nov 10, 2025
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
CareCloud Delivers Most Profitabl…
Published
Nov 5, 2026
View

Performance

5D 20D 120D MTD YTD
CCLD +5.2% +30.8% +9.5% +37.5% -17.1%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +2.6% +32.0% +9.0% +37.7% -27.7%
Key facts CIK 1582982 CUSIP 14167R100 13F (30d) 64 filings 45 filers Visit website Investor relations